LISATA THERAPEUTICS, INC.
Tremor tracks 1 of its cancer trials.
Company-wide warning signs
These add points to every one of this company's trials.
- A key executive is leavingSince Aug 4, 2026+5.1
- Announced layoffs or restructuringSince Aug 4, 2026+5.1
Trials
Key executives leaving
From the last 12 months of the company's SEC reports.
Aug 4, 2026
“Buck, M.D., the Company’s Executive Vice President of R&D and Chief Medical Officer was terminated.”
Read the filing ↗
Insider trades (last 6 months)
“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.
0 sales (0 not pre-planned) · 0 purchases
No insider sales or purchases in the last 6 months.
Recent SEC filings
Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.
- An executive or board member joined or leftNews report (8-K)Oct 14, 2026
- Signed a major agreement; An executive or board member joined or left; Shared information with investorsNews report (8-K)Sep 17, 2026
- Quarterly reportQuarterly report (10-Q)Aug 6, 2026
- A key executive is leavingNews report (8-K)Aug 4, 2026
- Ended a major agreement; Other newsNews report (8-K)Jul 24, 2026
Money left
Coming soon: how many months of cash the company has, from its quarterly reports.